News

The Australian Patent Office has granted the company a patent that contains formulation and method claims to a pharmaceutical formulation comprising a macromolecular pharmaceutical agent in mixed micellar

The FDA has previously granted the product fast track designation and approved a rolling new drug application (NDA) submission schedule. The company has recently announced results of the

The planned expansion added a second freestanding 20,000 square feet building to the existing campus. The new $3.5 million facility houses SpectraCell’s clinical laboratory operations while the existing

The study is designed to evaluate IPI-504 as a monotherapy in patients with stage IIIb/IV non-small cell lung cancer (NSCLC) whose tumors have relapsed or become refractory to

Under the terms of the agreement, Merck Serono will provide Lpath up to $23 million of upfront payments and R&D funding to support Lpath’s completion of the Phase

The product will be marketed under store brand labels and is comparable to Wyeth consumer healthcare’s Advil PM tablets, 200/38mg, indicated as a pain reliever or nighttime sleep-aid.

The agreement provides Ultra Ultrasonik with the rights to sell in Turkey and includes minimum purchase requirements. The SonaStar is used by neuro and general surgeons for quick

The first new type of blood pressure medicine in over a decade Rasilez, known as Tekturna in the US, provides effective blood pressure lowering that lasts beyond 24

The two-arm, randomized, multi-dose, double-blind, placebo-controlled study included Rhinocort as the steroid comparator arm. A secondary efficacy endpoint of this study was the effect of MRX-4 on inflammatory